Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on September 23, 2026

Sep. 23, 2026

BioAro Launches AI-Assisted LONgevity+™ Bioactives in the U.S. and U.K.

Indeterminate GlobeNewswire

Sep. 23, 2026

PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures

Indeterminate GlobeNewswire

Sep. 23, 2026

Synack Integrates with Wiz to Unify Pentest Findings Alongside Cloud Security Data

Indeterminate GlobeNewswire

Sep. 23, 2026

EFI to Showcase Sign and Display Graphics Innovations and Workflow Automation Tools at PRINTING United Expo

Indeterminate GlobeNewswire

Sep. 23, 2026

Magnite Named Primary Video Ad Server and a Programmatic Technology Provider for HP TV+

Indeterminate GlobeNewswire

Sep. 23, 2026

Altimmune to Participate in Stifel Cardiometabolic Forum

Indeterminate GlobeNewswire

Sep. 23, 2026

Adaptyx Biosciences Granted FDA Breakthrough Device Designation For Its Continuous Cortisol Monitoring Technology and Is Accepted into FDA’s Total Product Life Cycle Advisory Program

Indeterminate GlobeNewswire

Sep. 23, 2026

Rezolve Ai Expects Substantially Lower Cash Burn in H2 2026 and Accelerated Path to Profitability

Indeterminate GlobeNewswire

Sep. 23, 2026

BIO-key Receives FIDO Alliance Full Certification for Passkey:YOU™ Authentication, Unlocking New Markets Including Agentic AI Authenticated Controls

Indeterminate GlobeNewswire

Sep. 23, 2026

Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations

Indeterminate GlobeNewswire

Sep. 23, 2026

Adjournment of Second Court Hearing

Indeterminate GlobeNewswire

Sep. 23, 2026

Ajournement de la deuxième audience devant le tribunal

Indeterminate GlobeNewswire

Sep. 23, 2026

3 E Network Advances European AI Data Center Project Through Nordic Subsidiary Aurora Core Technology Oy

Indeterminate GlobeNewswire

Sep. 23, 2026

Acoramidis Demonstrates Real-World Benefit Versus Tafamidis in ATTR-CM, Reducing Risk of Clinical Worsening

Indeterminate GlobeNewswire

Sep. 23, 2026

Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings

Indeterminate GlobeNewswire

Sep. 23, 2026

Entente Education Canada urges federal government to take steps to improve cash flow and tax fairness for seniors, caregiver support

Indeterminate GlobeNewswire

Sep. 23, 2026

Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity

Indeterminate GlobeNewswire

Sep. 23, 2026

Cineplex Appoints Bill Walker as Chief Executive Officer and Announces Strategic Review

Indeterminate GlobeNewswire

Sep. 23, 2026

Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease

Indeterminate GlobeNewswire

Sep. 23, 2026

SOPRIS TECHNOLOGIES Appoints Global Business Leader Robert Vrij to Board of Directors

Indeterminate GlobeNewswire